1. Armitage JO, Corder MP, Leimert JT, Dick FR, Elliott TE (1980) Advanced diffuse histiocytic lymphoma treated with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) without maintenance therapy. Cancer Treat Rep 64: 649–654
2. Armitage JO, Potter JF (1984) Aggressive chemotherapy for diffuse histologic lymphoma in the elderly: Increased complication with advancing age. J Am Geriatr Soc 32: 269–273
3. Brittinger G, Bartels H, Common H, Dühmke E, Fülle HH, Gunzer U, Gyenes T, Heinz R, König E, Meusers P, Paukstat M, Pralle H et al. (1984) Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas. Results of a prospective multicenter study by the Kiel Lymphoma Study Group. Hematol Oncol 2: 269–306
4. Brittinger G, Engelhard M (1988) Trends der Chemotherapie von Non-Hodgkin-Lymphomen. In: Lutz D, Heinz R, Nowotny H, Stacher A (eds) Leukämien und Lymphome. Fortschritte und Hoffnungen. Urban und Schwarzenberg, München Wien Baltimore, pp 110–115
5. Carbone PP, Kaplan NS, Musshoff K, Smithies DW, Tubiana M (1971) Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31: 1860–1861